Compass Therapeutics (CMPX) Debt Ratio (2019 - 2021)

Compass Therapeutics (CMPX) has 3 years of Debt Ratio data on file, last reported at 0.11 in Q3 2021.

• For the quarter ending Q3 2021, Debt Ratio fell 41.82% year-over-year to 0.11; the trailing twelve-month figure through Sep 2021 stood at 0.11 (down 41.82% YoY), and the FY2020 full-year result was 0.18, down 63.26% from the prior year.
• Debt Ratio eased to 0.11 in Q3 2021, from 0.16 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.49 in Q4 2019 to a low of 0.11 in Q3 2021.
• A 3-year average of 0.22 and a median of 0.18 in 2020 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio plunged 63.26% in 2020 and tumbled 41.82% in 2021, its largest moves.
• Tracing CMPX's Debt Ratio over 3 years: stood at 0.49 in 2019, then plunged by 63.26% to 0.18 in 2020, then slumped by 40.34% to 0.11 in 2021.
• Business Quant data shows CMPX's Debt Ratio at 0.11 in Q3 2021, 0.16 in Q1 2021, and 0.18 in Q4 2020.